Three-year Follow-Up Analysis of Phase 1/2 Study on Tirabrutinib in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma.
Neuro-Oncology Advances（2024）
关键词
BTKi,Bruton's tyrosine kinase inhibitor,ONO-4059,PCNSL,primary central nervous system lymphoma,tirabrutinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要